Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab ; volume:11 ; number:3 ; year:2020 ; pages:652-657
Case reports in ophthalmology ; 11, Heft 3 (2020), 652-657
- Creator
-
Britton, Anna Krystyna
Crayford, Basil Bamford
- DOI
-
10.1159/000510114
- URN
-
urn:nbn:de:101:1-2021011323310131264061
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Britton, Anna Krystyna
- Crayford, Basil Bamford
Other Objects (12)
Therapeutic approaches for corneal neovascularization
Inhibition of corneal neovascularization with propolis extract
Three-year follow-up of high-risk keratoplasty following fine-needle diathermy of corneal neovascularization combined with bevacizumab
Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo
Treatment of corneal neovascularization in ocular chemical injury with an off-label use of subconjunctival bevacizumab: a case report
Angiogenin ameliorates corneal opacity and neovascularization via regulating immune response in corneal fibroblasts
MiR-335 promotes corneal neovascularization by Targeting EGFR
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Inhibitory effect of anti-Scg3 on corneal neovascularization: a preliminary study
Occult retinal neovascularization following intravitreal bevacizumab and laser treatment for retinopathy of prematurity
Ocular Syphilis with Retinal and Disc Neovascularization Treated with Bevacizumab: A Case Report
Cannabinoid (JWH-133) therapy could be effective for treatment of corneal neovascularization
Therapeutic approaches for corneal neovascularization
Inhibition of corneal neovascularization with propolis extract
Three-year follow-up of high-risk keratoplasty following fine-needle diathermy of corneal neovascularization combined with bevacizumab
Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo
Treatment of corneal neovascularization in ocular chemical injury with an off-label use of subconjunctival bevacizumab: a case report
Angiogenin ameliorates corneal opacity and neovascularization via regulating immune response in corneal fibroblasts
MiR-335 promotes corneal neovascularization by Targeting EGFR
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Inhibitory effect of anti-Scg3 on corneal neovascularization: a preliminary study
Occult retinal neovascularization following intravitreal bevacizumab and laser treatment for retinopathy of prematurity
Ocular Syphilis with Retinal and Disc Neovascularization Treated with Bevacizumab: A Case Report
Cannabinoid (JWH-133) therapy could be effective for treatment of corneal neovascularization
Therapeutic approaches for corneal neovascularization
Inhibition of corneal neovascularization with propolis extract
Three-year follow-up of high-risk keratoplasty following fine-needle diathermy of corneal neovascularization combined with bevacizumab
Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo
Treatment of corneal neovascularization in ocular chemical injury with an off-label use of subconjunctival bevacizumab: a case report
Angiogenin ameliorates corneal opacity and neovascularization via regulating immune response in corneal fibroblasts
MiR-335 promotes corneal neovascularization by Targeting EGFR
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Inhibitory effect of anti-Scg3 on corneal neovascularization: a preliminary study
Occult retinal neovascularization following intravitreal bevacizumab and laser treatment for retinopathy of prematurity
Ocular Syphilis with Retinal and Disc Neovascularization Treated with Bevacizumab: A Case Report